Fastenal, Arthur J. Gallagher: Smarter Picks

Large-cap stocks like Gilead Sciences may not offer the growth potential of smaller rivals. With a sluggish revenue growth of 3.6% over five years and shrinking returns on capital, Gilead trades at 15.5 times forward earnings. On the other hand, Fastenal and Arthur J. Gallagher show promise with impressive unit sales growth, high margins, and strong earnings. Fastenal, at 45 dollars per share, and Arthur J. Gallagher, at 220 dollars per share, present smarter investment options. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/91ef923db58e4986